Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Science (New York, N.Y.)|July 13, 1990
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosisH F Weisman, T Bartow, M K Leppo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectorsA L Tutt, R R French, T M Illidge, et al.
Immunological Reviews|July 10, 1999
Potential strategies utilised by papillomavirus to evade host immunityI H Frazer, R Thomas, J Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2017
Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distressA van Erkelens, A S Sie, P Manders, et al.
British Journal of Cancer|September 17, 2002
The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapyP Manders, L V A M Beex, V C G Tjan-Heijnen, et al.
Nucleic Acids Research|April 25, 1994
Antibodies generated from human immunoglobulin miniloci in transgenic miceS D Wagner, G T Williams, T Larson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancerN Hoogerbrugge, P Bult, L M de Widt-Levert, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2011
Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndromeP Manders, L Spruijt, C M Kets, et al.
Breast Cancer Research and Treatment|September 18, 2009
In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-upP Bult, P Manders, H M P M Straatman, et al.
Gynecologic Oncology|July 20, 2016
Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experienceM G Harmsen, M Arts-de Jong, K Horstik, et al.
Pageof 17